Author:
Elnakady Yasser A.,Rushdi Ahmed I.,Franke Raimo,Abutaha Nael,Ebaid Hossam,Baabbad Mohannad,Omar Mohamed O. M.,Al Ghamdi Ahmad A.
Publisher
Springer Science and Business Media LLC
Reference105 articles.
1. Torre, L. A. et al. Global cancer statistics, 2012. CA: a cancer journal for clinicians 65, 87–108, doi: 10.3322/caac.21262 (2015).
2. Walker, F. E. Paclitaxel (TAXOL): side effects and patient education issues. Seminars in oncology nursing 9, 6–10 (1993).
3. Uchida, J. et al. Comparison of side effects caused by intra-arterial and intravenous infusion of M-VAC (methotrexate, vinblastine, adriamycin and cisplatin) for urothelial cancer. Hinyokika kiyo. Acta urologica Japonica 43, 637–640 (1997).
4. Brockmann, B., Geschke, E., Schmidt, U. M. & Ebeling, K. Therapeutic results and toxic side effects of the cytostasan, adriamycin and vincristine combination as second line therapy in metastatic breast cancer. Geburtshilfe und Frauenheilkunde 51, 383–386, doi: 10.1055/s-2007-1026163 (1991).
5. Brockmann, B., Kirchhof, I., Geschke, E. & Schmidt, U. M. Therapeutic results and toxic side effects of the combination cytostasan, adriamycin and vincristine as second-line therapy of metastatic breast cancer. Archiv fur Geschwulstforschung 59, 341–346 (1989).
Cited by
63 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献